Abstract
BackgroundGNAO1 encephalopathy is a rare neurodevelopmental disorder characterized by distinct movement presentations and early onset epileptic encephalopathy. Here, we report the in-depth phenotyping of genetically confirmed patients with GNAO1 encephalopathy, focusing on movement presentations.ResultsSix patients who participated in Korean Undiagnosed Disease Program were diagnosed to have pathogenic or likely pathogenic variants in GNAO1 using whole exome sequencing. All medical records and personal video clips were analyzed with a literature review. Three of the 6 patients were male. Median follow-up duration was 41 months (range 7–78 months) and age at last examination was 7.4 years (range 3.3–16.9 years). Initial complaints were hypotonia or developmental delay in 5 and right-hand clumsiness in 1 patient, which were noticed at median age of 3 months (range 0–75 months). All patients showed global developmental delay and 4 had severely retarded development. Five patients (5/6, 83.3%) had many different movement symptoms with various onset and progression. The symptoms included stereotyped hands movement, non-epileptic myoclonus, dyskinesia, dystonia and choreoathetosis. Whole exome sequencing identified 6 different variants in GNAO1. Three were novel de novo variants and atypical presentation was noted in a patient. One variant turned out to be inherited from patient’s mother who had mosaic variant. Distinct and characteristics movement phenotypes in patients with variant p.Glu246Lys and p.Arg209His were elucidated by in-depth phenotyping and literature review.ConclusionsWe reported 6 patients with GNAO1 encephalopathy showing an extremely diverse clinical spectrum on video. Some characteristic movement features identified by careful inspection may also provide important diagnostic insight and practice guidelines.
Highlights
Since the first identification of GNAO1 as a new causative gene of early-onset epileptic encephalopathy in 2013, variable phenotypes have been reported [1,2,3]
The entire Korean Undiagnosed Disease Program (KUDP) protocol including diagnostic process and data sharing was approved by the Institutional Review Board (IRB) of Seoul National University Hospital (IRB No 1904-0541027) and written consent forms were obtained from all parents or their legal representatives
Five patients were referred to the clinic due to hypotonia or global developmental delay which was noticed at different ages (3 months old on median, range 0–75 months)
Summary
Since the first identification of GNAO1 as a new causative gene of early-onset epileptic encephalopathy in 2013, variable phenotypes have been reported [1,2,3]. Gain-of-function mutation (GOM) turned out to be associated with movement disorder [11]. It could not explain all the cases. Comprehensive and serial phenotyping would be the very first step to grasp the disease and establish further functional studies. GNAO1 encephalopathy is a rare neurodevelopmental disorder characterized by distinct movement presentations and early onset epileptic encephalopathy. We report the in-depth phenotyping of genetically confirmed patients with GNAO1 encephalopathy, focusing on movement presentations
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.